Global Information
회사소개 | 문의

세계의 니들 프리 딜리버리 기술 시장 전망(2018-2028년) : 제트 주사기 기술, 경쟁 기술(신형 니들 기술, 흡입기 기술, 경피 패치 기술)

Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology

리서치사 Visiongain Ltd
발행일 2018년 08월 상품 코드 233147
페이지 정보 영문 183 Pages
가격
£ 2,699 ₩ 3,888,000 Unprintable PDF (Single User) - 1 Year License help
1명만 이용할 수 있는 라이센스입니다. DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 인증된 PC 1대에서만 열람이 가능하며, 구입일로부터 1년간 유효합니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄 또한 불가능합니다.
£ 2,999 ₩ 4,321,000 PDF (Departmental - 5 Users) - 1 Year License help
동일 사업장(소재지) 내 5명까지 이용할 수 있는 라이센스입니다. DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 인증된 PC에서만 열람이 가능하며, 구입일로부터 1년간 유효합니다. PDF파일은 Copy & Paste가 되지 않으며, 인쇄는 1명당 1회에 한해 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
£ 4,999 ₩ 7,202,000 PDF (Site License) help
동일 사업장(소재지) 내 모든 분이 이용할 수 있는 라이센스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 되지 않습니다. DRM(디지털 저작권 관리시스템)은 적용되어 있지 않지만, PDF 인쇄는 1명당 1회에 한해 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
£ 6,999 ₩ 10,084,000 PDF (Global Site License - Includes Free Datasets) help
동일 기업의 전세계 분들이 이용할 수 있는 라이센스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste 가 되지 않습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 니들 프리 딜리버리 기술 시장 전망(2018-2028년) : 제트 주사기 기술, 경쟁 기술(신형 니들 기술, 흡입기 기술, 경피 패치 기술) Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology
발행일 : 2018년 08월 페이지 정보 : 영문 183 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 니들 프리 딜리버리 기술(Needle-Free Delivery Technology) 시장 규모는 2017년에 17억 달러, 2028년에는 55억 달러로, 11.5%의 CAGR(연평균 성장률)로 확대될 전망입니다. 2017년에 시장의 45.1%를 제트 주사기가 차지했습니다.

세계의 니들 프리(무바늘) 딜리버리 시장에 대해 조사분석했으며, 니들 프리 딜리버리 기술의 필요성 및 이점·결점, 현재 이용 가능/개발중인 주요 제품(제트 주사기, 경쟁 기술)의 개요, 시장 규모의 동향 전망, 각국 시장의 상세 동향, 주요 시장 촉진·억제요인, 주요 기업의 개요·주력 제품·실적 전망, 향후 시장 동향의 방향성 등을 정리하여 전해드립니다.

제1장 분석 개요

제2장 니들 프리 딜리버리 기술의 개요

  • 니들 프리(무바늘) 딜리버리 기술이란 무엇인가?
  • 니들 프리 딜리버리 기술 시장
  • 니들 프리 딜리버리 기술이 유용화되는 임상 현장
    • 통증 관리
    • 백신 전달 : 면역 반응 개선
    • 당뇨병용 인슐린 전달
    • 소아용 주사
    • 기타 이용법
  • 니들 프리 딜리버리 기술 시장에 관한 규제(미국·유럽)
  • 바이오의약품

제3장 니들 프리 딜리버리 기술 : 세계 시장

  • 시장 개요
  • 시장 내역
  • 시장 예측(향후 12년간)
  • 부문별 시장 점유율의 변동 전망
  • 향후 시장 동향
  • 시장 촉진·억제요인

제4장 제트 주사기 기술 시장

  • 제트 주사기 기술 : 개요
  • 제트 주사기 기술 : 시장 예측(향후 12년간)
  • 주요 제트 주사기 제품(총 15 제품)
  • 제트 주사기 개발 파이프라인(총 7 제품)

제5장 경쟁하는 니들 프리 딜리버리 기술 시장

  • 경쟁 기술의 개요
  • 경쟁 기술 시장 : 예측(향후 11년간)
  • 경쟁 기술 시장 : 부문별 시장 점유율의 변동 전망
  • 신형 니들 기술 : 개요
  • 신형 니들 기술 : 시장 예측(향후 11년간)
    • 주요 제품(총 5 제품)
    • 파이프라인 제품(총 11 제품)
  • 흡입기 기술 : 개요
  • 흡입기 기술 : 시장 예측(향후 12년간)
    • 천식용 흡입기
      • 방지약 흡입기
      • 완화약 흡입기
    • 인슐린용 흡입기
    • 백신용 흡입기
  • 경피 패치 기술 : 개요
  • 경피 패치 기술 : 시장 예측(향후 12년간)
    • 주요 경피 패치 제품(총 4 제품)
    • 경피 패치 기술의 개발 파이프라인(총 4 제품)
  • 개발중인 기타 경쟁 기술(총 4 제품)

제6장 주요 국가 시장(향후 11년간)

  • 세계의 니들 프리 딜리버리 기술 시장 : 지역별 예측(향후 11년간)
    • 지역별 시장 점유율의 변동 전망
  • 미국 시장
  • 유럽 주요 5개국 시장(EU5 : 독일·프랑스·영국·이탈리아·스페인)
  • 일본 시장
  • 중국 시장
  • 인도 시장
  • 기타 국가(RoW) 시장

제7장 니들 프리 딜리버리 기술의 대표적 기업

  • 니들 프리 딜리버리 기술의 주요 제조업체
  • Antares Pharma
  • Zogenix
  • 3M
  • Becton Dickinson and Company(BD)
  • PharmaJet
  • BioJect Medical Technologies

제8장 니들 프리 딜리버리 기술 시장의 정성 분석

  • 니들 프리 딜리버리 기술의 SWOT 분석
  • 강점
    • 바이오의약품 시장의 대폭적인 성장
    • 경피 전달 기술의 진보
    • 전문적 훈련이 불필요하며 사고도 발생하지 않음
    • 콜드체인 문제의 회피
  • 약점
    • 새로운 딜리버리 시스템에 익숙하지 않은 의료 종사자
    • 규제·검사의 강화
    • 비효율적인 제조 공정
  • 기회
    • 신흥 경제국의 거대한 성장 기회
    • 세계 각지에서의 집단 예방 접종 프로그램
    • 가정용 치료로의 이동
    • 약제의 수명주기 연장
  • 위협
    • 기존형 주사바늘·시린지 : 대량생산에 의한 낮은 제조 비용
    • 사고 방지 기술 장착 주사바늘·시린지
    • 임상 데이터의 부족
    • 의료기기용 물품세

제9장 결론

  • 현재 주력 부문
    • 주목해야 할 기업
    • 주요 국가 시장
  • 세계 시장 예측(향후 11년간)
  • 니들 프리 딜리버리 기술 시장의 미래
    • 바이오시밀러 : 니들 프리 딜리버리 기술 시장의 강력한 촉진요인
    • 강력한 파이프라인 제품 : 니들 프리 딜리버리 기술의 촉진요인

부록

  • 용어집
KSA 18.10.15

List of Tables

  • Table 2.1: Classification of Jet Injectors by Method of Propulsion
  • Table 2.2: Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3: Pen Needle Technology by Needle Length
  • Table 2.4: Rationale for Needle-Free Vaccine Delivery
  • Table 2.5: Examples of Needle-Free Vaccine Delivery Systems, 2016
  • Table 2.6: Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016
  • Table 2.7: FDA Guidance on Regulation of Needle-Free Injectors, 2015
  • Table 2.8: Top 5 Biologics by Sales ($bn), 2015
  • Table 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015
  • Table 3.2: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 3.3: Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026
  • Table 4.1: The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2: Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015
  • Table 5.3: Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.4: Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.5: Leading Products in the Asthma Preventer Inhaler Market, 2016
  • Table 5.6: Leading Products in the Asthma Reliever Inhaler Market, 2016
  • Table 5.7: Vaccine Inhalers Currently Under Development, 2016
  • Table 5.8: Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.9: Transdermal Patch Products, 2016
  • Table 6.1: Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026
  • Table 6.2: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Table 6.3: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Table 6.4: US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.5: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.6: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026
  • Table 6.7: German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.8: French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.9: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.10: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.11: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.12: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.13: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.14: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 7.1: Antares Pharma: Overview, 2016
  • Table 7.2: Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3: Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.4: Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.5: Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.6: Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7: Zogenix: Overview, 2016
  • Table 7.8: Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.9: Zogenix: Revenue ($m) by Type, 2010-2015
  • Table 7.10: 3M: Overview, 2016
  • Table 7.11: 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.12: BD: Overview, 2016
  • Table 7.13: BD: Drug Delivery Products by Segment, 2016
  • Table 7.14: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Table 7.15: BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.16: PharmaJet: Overview, 2016
  • Table 7.17: BioJect Medical Technologies: Overview, 2016
  • Table 7.18: Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19: Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 8.1: SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026
  • Table 8.2: Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015

List of Figures

  • Figure 1.1: Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
  • Figure 2.1: Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 3.2: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015
  • Figure 3.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 3.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 3.5: Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
  • Figure 4.1: The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.1: The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.2: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015
  • Figure 5.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 5.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 5.5: Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.6: Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.7: Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.1: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Figure 6.2: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020
  • Figure 6.3: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026
  • Figure 6.4: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026
  • Figure 6.5: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Figure 6.6: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020
  • Figure 6.7: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026
  • Figure 6.8: US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.9: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026
  • Figure 6.10: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015
  • Figure 6.11: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020
  • Figure 6.12: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026
  • Figure 6.13: German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.14: French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.15: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.16: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.17: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.18: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.19: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.20: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 7.1: Antares Revenue from Major Customers: Revenue Share (%), 2014
  • Figure 7.2: Antares Revenue from Major Customers: Revenue Share (%), 2015
  • Figure 7.3: Antares Revenue by Region: Revenue Share (%), 2014
  • Figure 7.4: Antares Revenue by Region: Revenue Share (%), 2015
  • Figure 7.5: Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.6: Zogenix: Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.7: Zogenix: Revenue ($m) by Type, 2014
  • Figure 7.8: Zogenix: Revenue ($m) by Type, 2015
  • Figure 7.9: 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.10: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Figure 7.11: BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.12: Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13: Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1: The Transport Process for a Vaccine

Companies Listed

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organisations Mentioned in the Report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital

The global needle-free delivery technology market was valued at $1.7bn in 2017 and is estimated to reach $5.5bn by 2028, growing at a CAGR of 11.5% from 2018-2028. In 2017, the Jet Injectors submarket held 45.1% of the global needle-free delivery technology market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 183-page report you will receive 107 charts - all unavailable elsewhere.

The 183-page report provides clear detailed insight into the global needle-free delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Needle-Free Delivery Technology market forecasts from 2018-2028
  • Jet Injector submarket forecasts from 2018-2028
  • Competing Technology submarket forecast from 2018-2028, further segmented into:
    • Novel Needle Technology
    • Inhaler Technology
    • Patch Technology
  • This report also breaks down the revenue forecast for global needle-free delivery technology market by regional and national market:
    • The US
    • EU5: Germany, France, UK, Italy, Spain
    • Japan
    • China
    • India

image1

  • This report discusses the leading companies that are involved in the needle-free delivery technology market. It contains overviews of the companies' activities, strategies and recent financial results:
    • 3M
    • Antares Pharma
    • Becton Dickinson
    • BioJect Medical Technologies
    • PharmaJet
    • Zogenix
  • This report provides a SWOT Analysis of the global needle-free delivery technology market.

Visiongain's study is for everybody needing commercial analyses for the needle-free delivery technology market and leading companies. You will find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 Global Needle-Free Delivery Technology Market Overview
  • 1.2 Global Needle-Free Delivery Technology Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to Needle-Free Delivery Technology

  • 2.1 What is Needle-Free Delivery Technology?
    • 2.1.1 Needlestick Injury
      • 2.1.1.1 Blood-Borne Pathogens and Needlestick Injury
      • 2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem
  • 2.2 The Needle-Free Delivery Technology Market
    • 2.2.1 Jet Injectors
      • 2.2.1.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
      • 2.2.1.2 Strengths and Weaknesses of Jet Injectors
    • 2.2.2 Competing Needle-Free Technologies
      • 2.2.2.1 Novel Needle Technology
      • 2.2.2.2 Pen Needles
      • 2.2.2.3 Microneedles
      • 2.2.2.4 Hollow Microneedles
      • 2.2.2.5 Solid Coated Microneedles
      • 2.2.2.6 Solid Biodegradable Microneedles
      • 2.2.2.7 Solid Uncoated Microneedles
      • 2.2.2.8 Using the Right Microneedles
      • 2.2.2.9 Inhaler Technology
      • 2.2.2.10 Transdermal Patch Technology
  • 2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
    • 2.3.1 Pain Management
      • 2.3.1.1 Using Needle-Free Injection Devices to Administer Lidocaine
    • 2.3.2 Vaccine Delivery: Improving Immune Response
      • 2.3.2.1 Needle-Free Vaccine Delivery
      • 2.3.2.2 Mass Immunisation
    • 2.3.3 Insulin Delivery for Diabetics
    • 2.3.4 Paediatric Injections
    • 2.3.5 Other Uses for Needle-Free Injection Technology
  • 2.4 Regulation of the Needle-Free Delivery Technology Market
    • 2.4.1 The US Regulation System
      • 2.4.1.1 Combination Products
      • 2.4.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices
    • 2.4.2 The European Regulation System
      • 2.4.2.1 Post Marketing Surveillance in the EU
  • 2.5 Biopharmaceuticals
    • 2.5.1 An Introduction to the Biological Drugs Market
    • 2.5.2 Biologics: A Rising Drugs Market

3. Needle-Free Delivery Technology: Global Market 2018-2028

  • 3.1 The Needle-Free Delivery Technology Market: Overview
  • 3.2 Needle-Free Delivery Technology Market Segmentation, 2017
  • 3.3 The Needle-Free Delivery Technology Market Forecast, 2017-2028
  • 3.4 How Will Segmental Market Shares Change to 2028?
  • 3.5 Needle-Free Delivery Technology: Market Trends, 2018-2028
  • 3.6 Needle-Free Delivery Technology: Drivers and Restraints 2018-2028

4. Jet Injectors Technology Market, 2018-2028

  • 4.1 The Jet Injectors Market Overview
  • 4.2 Jet Injectors: Market Forecast 2017-2028
  • 4.3 Jet Injector Devices on the Market
    • 4.3.1 Biojector 2000 (Bioject Medical Technologies)
    • 4.3.2 ZetaJet (Bioject Medical Technologies)
    • 4.3.3 Vision (Antares Pharma)
    • 4.3.4 Vibex (Antares Pharma)
    • 4.3.5 Sumavel DosePro (Endo International)
    • 4.3.6 Stratis (PharmaJet)
    • 4.3.7 LectraJet (D'Antonio Consultants International)
    • 4.3.8 AdvantaJet and GentleJet (Activa Brand Products)
    • 4.3.9 Vitajet (Bioject Medical Technologies)
    • 4.3.10 Med-Jet (Medical International Technologies)
    • 4.3.11 J-Tip (National Medical Products)
    • 4.3.12 Injex30 (Injex Pharma)
    • 4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak)
    • 4.3.14 E-Jet 100 (Eurojet Medical)
    • 4.3.15 Penjet (Penjet Corporation)
  • 4.4 Jet Injectors Development Pipeline
    • 4.4.1 Glide SDI (Glide Pharmaceutical Technologies)
    • 4.4.2 Zeneo (Crossject)
    • 4.4.3 Relday (Zogenix)
    • 4.4.4 Magnetic Injection (Massachusetts Institute of Technology)
    • 4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies)
    • 4.4.6 Iject and Iject R (Bioject Medical Technologies)
    • 4.4.7 Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2018-2028

  • 5.1 The Competing Needle-Free Technology Overview
  • 5.2 The Competing Technology: Market Forecast 2017-2028
  • 5.3 How Will Segmental Market Shares Change to 2028?
  • 5.4 Novel Needle Technology Overview
  • 5.5 Novel Needle Technology: Market Forecast, 2018-2028
    • 5.5.1 Leading Novel Needle Technologies
      • 5.5.1.1 Soluvia Microinjection System (BD)
      • 5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD)
      • 5.5.1.3 AutoShield Duo Pen Needle (BD)
      • 5.5.1.4 Microstructured Transdermal Systems (3M)
      • 5.5.1.5 ZP Patch Technology (Zosano)
    • 5.5.2 Novel Needle Technology Development Pipeline
      • 5.5.2.1 Microneedle Patch (Georgia Institute of Technology)
      • 5.5.2.2 Micronjet (NanoPass)
      • 5.5.2.3 DebioJect (Debiotech)
      • 5.5.2.4 AdminPen (nanoBioSciences)
      • 5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp)
      • 5.5.2.6 DrugMat and VaxMat (TheraJect)
      • 5.5.2.7 MicroCor (Corium International)
      • 5.5.2.8 Nanopatch (Vaxxas)
      • 5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
      • 5.5.2.10 Memspatch and Micro-Patch (Nemaura)
      • 5.5.2.11 Microneedle Patch for Lidocaine Delivery (National University of Singapore)
  • 5.6 Inhaler Technology Overview
  • 5.7 Inhaler Technology: Market Forecast, 2017-2028
    • 5.7.1 Inhaler Products in the Asthma Market
      • 5.7.1.1 Preventer Inhalers
      • 5.7.1.2 Reliever Inhalers
    • 5.7.2 Inhaler Products in the Insulin Market
    • 5.7.3 Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune)
      • 5.7.3.1 Pipeline
  • 5.8 Transdermal Patch Technology Overview
  • 5.9 Transdermal Patch Technology: Market Forecast, 2017-2028
    • 5.9.1 Selected Transdermal Patch Products
      • 5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals)
      • 5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline)
      • 5.9.1.3 Exelon Patch (Rivastigmine, Novartis)
      • 5.9.1.4 Zecuity (Sumatriptan, Teva)
    • 5.9.2 Transdermal Patch Technology Development Pipeline
      • 5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma)
      • 5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
      • 5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
      • 5.9.2.4 Prelude SkinPrep System (Echo Therapeutics)
  • 5.10 Other Competing Needle-free delivery Technology in development
    • 5.10.1 Microbubbles Injection (Shibaura Institute of Technology)
    • 5.10.2 Laser Injection (Seoul National University)
    • 5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
    • 5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2017-2028

  • 6.1 Global Needle-Free Delivery Technology Market: Regional Forecast 2018-2028
    • 6.1.1 How Will Regional Market Shares Change to 2026?
  • 6.2 The US Needle-Free Delivery Technology Market 2018-2028
    • 6.2.1 US Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.2.2 FDA Guideline for Combination Products
    • 6.2.3 Needle-Free Delivery and the US Flu Vaccination Market
    • 6.2.4 Measles Outbreak in the US
  • 6.3 The EU5 Needle-Free Delivery Technology Market 2017-2028
    • 6.3.1 EU5 Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.3.2 Germany Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.3 France Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.4 The UK Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.5 Italy Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.6 Spain Needle-Free Delivery Technology Market Forecast, 2018-2028
  • 6.4 Japan Needle-Free Delivery Technology Market 2018-2028
    • 6.4.1 Japan Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.5 China Needle-Free Delivery Technology Market 2018-2028
    • 6.5.1 China Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.6 India Needle-Free Delivery Technology Market 2018-2028
    • 6.6.1 India Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.6.2 Needles and Syringes being Re-used in Indian Hospitals
  • 6.7 The Rest of the World (RoW) Needle-Free Delivery Technology Market 2018-2028
    • 6.7.1 RoW Needle-Free Delivery Technology Market Forecast 2018-2028

7. Leading Companies in the Needle-Free Delivery Technology Market

  • 7.1 Leading Needle-Free Delivery Technology Manufacturers in 2017
  • 7.2 Antares Pharma: Leading the Needle-Free Injector Market
    • 7.2.1 Antares Pharma: Needle-Free Technology Product Portfolio
    • 7.2.2 Antares Pharma: Future Outlook
    • 7.2.3 Antares Pharma: Products in Development
    • 7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
  • 7.3 Zogenix
    • 7.3.1 Zogenix: Product Portfolio
    • 7.3.2 Zogenix: Current Pipeline
    • 7.3.3 Zogenix: Financial Overview
  • 7.4 3M: 50 Years of Drug Delivery Technology Development
    • 7.4.1 3M: Drug Delivery Technology Portfolio
    • 7.4.1.1 Oral and Topical Drug Delivery
    • 7.4.1.2 MDI for Nasal and Inhalable Drugs
    • 7.4.1.3 Transdermal patch Technology
    • 7.4.1.4 Microneedle Technology
    • 7.4.2 3M: Market Outlook
  • 7.5 Becton Dickinson and Company (BD)
    • 7.5.1 BD: Drug Delivery Technology Portfolio
    • 7.5.1.1 Prefillable Syringe Systems
    • 7.5.1.2 Self-Injection Systems
    • 7.5.1.3 Pen Needles
    • 7.5.1.4 Safety & Shielding Systems
    • 7.5.2 BD: Future Outlook
    • 7.5.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
    • 7.5.4 BD Acquired Injection Safety Firms
    • 7.5.5 Recall of BD Needles in Hong Kong
  • 7.6 PharmaJet
    • 7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio
    • 7.6.2 First FDA Approved Jet Injector for Flu Shot in the US
    • 7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
    • 7.6.4 Preference for PharmaJet over Needle and Syringe
  • 7.7 BioJect Medical Technologies
    • 7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
    • 7.7.2 Bioject Medical Technologies: Financial Overview
    • 7.7.3 Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2017-2028

  • 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market
  • 8.2 Strengths
    • 8.2.1 Strong Growth in the Biologic Drug Market
    • 8.2.2 Increasing Development in Transdermal Delivery
    • 8.2.3 No Specialist Training Required and No Needlestick Injuries
    • 8.2.4 Eliminating the Cold Chain Problem
  • 8.3 Weaknesses
    • 8.3.1 Healthcare Practitioners are not familiar with Novel Delivery Systems
    • 8.3.2 Greater Regulatory Scrutiny
    • 8.3.3 Inefficient Manufacturing Processes
  • 8.4 Opportunities
    • 8.4.1 Emerging Economies Offer Significant Growth Opportunities
    • 8.4.2 Mass Immunisation Programmes around the World
    • 8.4.3 Increasing Global Diabetic Population
    • 8.4.4 Shift towards Home Administration Setting
    • 8.4.5 Extending Life Cycle of Drugs
  • 8.5 Threats
    • 8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
    • 8.5.2 Needle and Syringes with Anti Needlestick Injury Technology
    • 8.5.3 Limited Clinical Data
    • 8.5.4 Medical Device Excise Tax

9. Conclusions

  • 9.1 Current Leading Needle-Free Technology Segments
    • 9.1.1 Notable Needle-Free Technology Companies
    • 9.1.2 Leading Regional Markets
  • 9.2 Global Needle-Free Technology Market Forecast 2018-2028
  • 9.3 The Future of the Needle-Free Technology Market
    • 9.3.1 Biosimilars are a Major Driver of the Needle-free Delivery Market
    • 9.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

Appendices

  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 2.1 Classification of Jet Injectors by Method of Propulsion
  • Table 2.2 Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3 Pen Needle Technology by Needle Length
  • Table 2.4 Rationale for Needle-Free Vaccine Delivery
  • Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2017
  • Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2017
  • Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2017
  • Table 2.8 Top 5 Biologics by Sales ($bn) in U.S, 2017
  • Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2017
  • Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 3.3 Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2017, 2022 and 2028
  • Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.2 Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2017
  • Table 5.3 Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.4 Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.5 Leading Products in the Asthma Preventer Inhaler Market, 2017
  • Table 5.6 Leading Products in the Asthma Reliever Inhaler Market, 2017
  • Table 5.7 Vaccine Inhalers Currently Under Development, 2017
  • Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.9 Transdermal Patch Products, 2017
  • Table 6.1 Global Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%) by Region, 2017-2028
  • Table 6.2 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017-2028
  • Table 6.3 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Table 6.4 US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.5 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.6 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017, 2022 and 2028
  • Table 6.7 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.8 France Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.9 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.10 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.11 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.12 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.13 China Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.14 India Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.15 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 7.1 Antares Pharma: Overview, 2017
  • Table 7.2 Antares Pharma: 2017 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3 Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.4 Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.5 Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.6 Antares Pharma: Products in Development 2017 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7 Zogenix: Overview, 2017
  • Table 7.8 Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.9 Zogenix: Revenue ($m) by Type, 2016 & 2017
  • Table 7.10 3M: Overview, 2017
  • Table 7.11 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.12 BD: Overview, 2017
  • Table 7.13 BD: Drug Delivery Products by Segment, 2017
  • Table 7.14 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Table 7.15 BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.16 PharmaJet: Overview, 2017
  • Table 7.17 BioJect Medical Technologies: Overview, 2017
  • Table 7.18 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19 Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2014
  • Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2017-2028
  • Table 8.2 Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2017

List of Figures

  • Figure 1.1 Global Needle-Free Delivery Technology Market Segmentation Overview, 2017
  • Figure 2.1 Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2017
  • Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints
  • Figure 4.1 The Jet Injectors Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2017
  • Figure 5.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 5.5 Novel Needle Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 5.7 Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 6.1 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Figure 6.2 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2022
  • Figure 6.3 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
  • Figure 6.4 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2028
  • Figure 6.5 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017
  • Figure 6.6 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2022
  • Figure 6.7 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2028
  • Figure 6.8 US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.9 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), 2017-2028
  • Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017
  • Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2022
  • Figure 6.12 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2028
  • Figure 6.13 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.14 France Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.15 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.16 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.17 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.18 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.19 China Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.20 India Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.21 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 7.1 Antares Revenue from Major Customers: Revenue Share (%), 2016
  • Figure 7.2 Antares Revenue from Major Customers: Revenue Share (%), 2017
  • Figure 7.3 Antares Revenue by Region: Revenue Share (%), 2016
  • Figure 7.4 Antares Revenue by Region: Revenue Share (%), 2017
  • Figure 7.5 Antares Pharma: Historical Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.6 Zogenix: Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.7 Zogenix: Revenue ($m) by Type, 2016
  • Figure 7.8 Zogenix: Revenue ($m) by Type, 2017
  • Figure 7.9 3M: Health Care Historical Revenue ($bn) and AGR (%), 2013-2017
  • Figure 7.10 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Figure 7.11 BD Medical: Historical Revenue ($bn) and AGR (%), 2013-2015
  • Figure 7.12 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1 The Transport Process for a Vaccine

COMPANIES LISTED

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Permatec
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • Tev-Tropin
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organizations Mentioned in the report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
Back to Top
전화 문의
이용안내
 
BCC Research